Linked issuers
4
Reporting Owner Activity for Paolo Pucci
Form 3/4/5 issuer links and transaction evidence for this reporting owner.
Largest position
WEST PHARMACEUTICAL SERVICES INC
Disclosed value
$3.09M
Transaction activity
Available
- Forms 3/4/5 ownership snapshot
-
Forms 3/4/5 show reporting-owner positions and transactions. They are useful ownership-context signals, not a complete public-float ownership table.
Estimated Forms 3/4/5 ownership value
$3.09MEstimated from parsed Forms 3/4/5 when filings include enough holding data.
Issuers linked to this owner
4Distinct issuers connected to this reporting owner in parsed SEC filings.
Largest linked issuer position
$2.97M estimated from parsed reporting-owner filings.
Latest parsed reporting-owner filing
06 May 2026Most recent reporting-owner filing date in the parsed SEC record.
How to read Forms 3/4/5 positions
- Reported values are filing-backed estimates from parsed SEC Forms 3/4/5 when the filing includes enough price and share data.
- Use this as reporting-owner context, not as a complete capitalization table.
- Location
- Burlington, MA
- Latest reporting-owner signature
- /s/ Louis Lalli, as an agent for Paolo Pucci
- SEC filing history
- Open SEC filing history
Ownership signals
CIK-linked ownership evidence from parsed SEC filings.
1 signal
Identity
Who this page is about.
1 identity field
SEC source record
Original filing metadata and source links.
1 source field
Source evidence
Original filing metadata and source links.
1 source field
Follow Filing Activity
Follow Paolo Pucci and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.
Reported issuer positions for Paolo Pucci
WST
Forms 3/4/5
WEST PHARMACEUTICAL SERVICES INC
- Relationship
- Director
- Holdings value
- $2,971,161
- Past year net change
- Change %
- Report period
- 04 May 2026
MRUS
Forms 3/4/5
Merus N.V.
- Relationship
- Director
- Holdings value
- $119,571
- Past year net change
- Change %
- Report period
- 12 Dec 2025
REPL
Forms 3/4/5
Replimune Group, Inc.
- Relationship
- Director
- Holdings value
- Past year net change
- Change %
- Report period
- 01 Apr 2026
TRIL
Forms 3/4/5
Trillium Therapeutics Inc.
- Relationship
- Director
- Holdings value
- Past year net change
- Change %
- Report period
- 17 Nov 2021
Recent insider transactions for Paolo Pucci
| Sym | Company | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.